Olmesartan Tecnigen (Olmesartan Medoxomil)

Olmesartan medoxil, the active ingredient in Olmesartan Tecnigen, is an Angiotensin II receptor blocker (ARB) presented as a tablet for oral use. It is indicated for the management of hypertension in adults. GNH USA supplies Olmesartan Tecnigen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Olmesartan Tecnigen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Olmesartan Tecnogen acts on the renin‑angiotensin‑aldosterone system to lower blood pressure. It is used in several cardiovascular indications:

- Hypertension: helps lower systolic and diastolic blood pressure in adults. - Heart failure: used as part of combination therapy to improve outcomes. - Diabetic nephropathy: may delay progression of kidney damage associated with diabetes. - Post‑myocardial infarction: assists in blood‑pressure control after a heart attack. - Stroke prevention : contributes to secondary prevention of stroke in high‑risk patients. - Chronic kidney disease: aids in blood‑pressure management for kidney‑protective effects.

Olmesartan Tecnigen is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Dizziness or light‑headedness - Headache - Fatigue - Nasal congestion - Diarrhoea - Elevated blood‑potassium levels

Serious or Rare Side Effects: - Angio‑edema involving the face, lips or tongue - Severe hypotension - Acute kidney injury - Hyperkalemia leading to cardiac arrhythmia - Hepatic dysfunction - Allergic skin reactions such as Stevens‑Johnson syndrome

Olmesartan Tecnigen should be used with caution in certain clinical situations.

- Pregnancy: contraindicated in the second and third trimesters due to risk of fetal toxicity. - Breastfeeding: avoid because it may pass into breast milk. - Renal impairment: dose adjustment may be required; monitor kidney function. - Hyperkalemia risk: avoid concomitant potassium‑rich supplements or salts. - Drug‑interaction monitoring: review all concomitant medicines for additive blood‑pressure effects. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Olmesetarn Ol  

Major  t  t

t  t

t t  ",